RANDOMIZED PHASE II TRIAL OF NGR-HTNF AND CHEMOTHERAPY IN CHEMO-NAIVE PATIENTS WITH NON-SMALL CELL LUNG CANCER (NSCLC): PRELIMINARY RESULTS.

被引：0
|
作者：
Gregorc, Vanesa [1 ]
Zilembo, N. [2 ]
Grossi, Francesco
Rossoni, Gilda [1 ]
Pietrantonio, Filippo [2 ]
Rijavec, Erika
Bulotta, Alessandra [1 ]
Vitali, Milena [2 ]
Barletta, Giulia
Bergamaschi, Luca [2 ]
Platania, Marco [2 ]
Lambiase, Antonio
Bordignon, Claudio
机构：
[1] Ist Sci San Raffaele, Dept Oncol, Milan, Italy
[2] Ist Nazl Tumori, Naples, Italy
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
NSCLC; Chemotherapy; NGR-hTNF;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S661 / S662
页数：2
相关论文
共 50 条
  • [1] Randomized Phase II Trial of NGR-hTNF and Chemotherapy in Chemo-naive Patients With Non-small Cell Lung Cancer (NSCLC) - Preliminary Results
    Gregorc, V.
    Zilembo, N.
    Grossi, F.
    Rossoni, G.
    Pietrantonio, F.
    Rijavec, E.
    Citterio, G.
    Platania, M.
    Lambiase, A.
    Bordignon, C.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S596 - S596
  • [2] Randomized, phase II trial of NGR-hTNF and chemotherapy in chemotherapy-naive patients with non-small cell lung cancer (NSCLC): Preliminary results.
    Gregorc, V.
    Zilembo, N.
    Grossi, F.
    Rossoni, G.
    Pietrantonio, F.
    Rijavec, E.
    Bulotta, A.
    Vitali, M.
    Barletta, G.
    Bergamaschi, L.
    Platania, M.
    Caligaris-Cappio, F.
    Lambiase, A.
    Bordignon, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [3] Randomized phase II trial of NGR-hTNF in combination with standard chemotherapy in previously untreated non-small cell lung cancer (NSCLC).
    Gregorc, Vanesa
    Zilembo, Nicoletta
    Grossi, Francesco
    De Pas, Tommaso M.
    Rossoni, Gilda
    Pietrantonio, Filippo
    Rijavec, Erika
    Citterio, Giovanni
    Lambiase, Antonio
    Bordignon, Claudio
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [4] FRONT-LINE CHEMOTHERAPY WITH OR WITHOUT NGR-HTNF IN NON-SMALL CELL LUNG CANCER (NSCLC)
    Gregorc, V.
    Zilembo, N.
    Grossi, F.
    De Pas, T.
    Pietrantonio, F.
    Giovannini, M.
    Rossoni, G.
    Bulotta, A.
    Lambiase, A.
    Bordignon, C.
    ANNALS OF ONCOLOGY, 2012, 23 : 410 - 410
  • [5] NGR-hTNF plus chemotherapy as first-line therapy of non-small cell lung cancer (NSCLC).
    Gregorc, Vanesa
    Zilembo, Nicoletta
    Grossi, Francesco
    De Pas, Tommaso M.
    Rossoni, Gilda
    Pietrantonio, Filippo
    Rijavec, Erika
    Giovannini, Monica
    Citterio, Giovanni
    Lambiase, Antonio
    Bordignon, Claudio
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [6] Phase II trial of NGR-hTNF and doxorubicin in relapsed small cell lung cancer (SCLC)
    Vigano, M. G.
    Cavina, R.
    Novello, S.
    Grossi, F.
    Santoro, A.
    Gregorc, V.
    Scagliotti, G.
    Garassino, I. M.
    Rossoni, G.
    Levra, M. G.
    Genova, C.
    Caligaris-Cappio, F.
    Lambiase, A.
    Bordignon, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [7] Phase I/II trial of bexarotene (Targretin®) with chemotherapy for chemo-naive patients with advanced non-small cell lung cancer.
    Khuri, FR
    Rigas, JR
    Figlin, RA
    Gralla, RJ
    Reich, SD
    Hong, WK
    CLINICAL CANCER RESEARCH, 2000, 6 : 4487S - 4488S
  • [8] Phase II Trial of NGR-hTNF and Doxorubicin in Relapsed Small Cell Lung Cancer (SCLC)
    Vigano, M.
    Cavina, R.
    Novello, S.
    Grassi, F.
    Santoro, A.
    Gregorc, V.
    Rossoni, G.
    Levra, M. G.
    Lambiases, A.
    Bordignon, C.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S623 - S623
  • [9] A phase II randomized trial of vinorelbine plus cisplatin or docetaxel plus cisplatin in inoperable, chemo-naive non-small cell lung cancer patients
    Chen, Y
    Shih, J
    Tsai, C
    Perng, R
    Whang-Peng, J
    LUNG CANCER, 2005, 49 : S389 - S389
  • [10] A phase II study of docetaxel plus irinotecan (DOCIRI) in chemo-naive patients with non small cell lung cancer (NSCLC).
    Ziotopoulos, P
    Chandrinos, V
    Samaras, N
    Mylonaki, E
    Stergiou, J
    Zachariadis, E
    Tsiafaki, X
    Agelidou, A
    Ketepozidis, N
    Georgoulias, V
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 682S - 682S
12345